DiamiR LLC - Product Pipeline Analysis, 2023 Update

Summary


DiamiR LLC (DiamiR) is a medical device company. It carries out the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, and early and differential diagnosis. The company also offers microRNAs which are a class of small non-coding regulatory RNA molecules which modulate target gene expression and protein production. DiamiR offers a universal screening test comprised of organ-enriched microRNA panels which could be used to detect the presence of pathology in a particular organ or organ system. The company develops programs for neurodegenerative diseases, healthy aging and neurodevelopment disease. It has collaborations with academia, medical centers, disease foundations and industry. DiamiR is headquartered in Monmouth Junction, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company DiamiR LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


DiamiR LLC Company Overview
DiamiR LLC Company Snapshot
DiamiR LLC Pipeline Products and Ongoing Clinical Trials Overview
DiamiR LLC – Pipeline Analysis Overview
DiamiR LLC - Key Facts
DiamiR LLC - Major Products and Services
DiamiR LLC Pipeline Products by Development Stage
DiamiR LLC Pipeline Products Overview
CogniMIR
CogniMIR Product Overview
Diagnostic Assay - Amyotrophic Lateral Sclerosis
Diagnostic Assay - Amyotrophic Lateral Sclerosis Product Overview
Diagnostic Assay - Frontotemporal Degeneration
Diagnostic Assay - Frontotemporal Degeneration Product Overview
Diagnostic Assay - Parkinson's Disease
Diagnostic Assay - Parkinson's Disease Product Overview
Diagnostic Assay - Rett Syndrome
Diagnostic Assay - Rett Syndrome Product Overview
Mdx Test - Brain Aging
Mdx Test - Brain Aging Product Overview
Mdx Test - MCI-AD Progression
Mdx Test - MCI-AD Progression Product Overview
Mdx Test - Mild Cognitive Impairment
Mdx Test - Mild Cognitive Impairment Product Overview
Universal Screening Test
Universal Screening Test Product Overview
DiamiR LLC - Key Competitors
DiamiR LLC - Key Employees
DiamiR LLC - Locations And Subsidiaries
Head Office
Recent Developments
DiamiR LLC, Recent Developments
Oct 02, 2023: DiamiR Biosciences Announces Poster Presentation at 52nd Annual Meeting of Child Neurology Society
Jul 05, 2023: DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development
Jun 28, 2023: DiamiR Biosciences Announces Publication of Analytical Validation Data for its microRNA Testing Platform
Nov 28, 2022: DiamiR Biosciences Announces Poster Presentation at the Clinical Trials on Alzheimers Disease 2022 Annual Meeting
Feb 11, 2021: DiamiR receives USPTO notice of allowance for key patent covering the use of microRNA biomarkers from bodily fluids for diagnosis and monitoring of Rett Syndrome and other neurodevelopmental diseases
Oct 05, 2020: DiamiR announces oral presentation at 21st International Conference on Alzheimer's Drug Discovery
Oct 01, 2020: DiamiR awarded $3.86M in two grants from the NIH
May 27, 2020: DiamiR receives USPTO notice of allowance for key patent covering the use of circulating brain-enriched microRNA biomarkers for monitoring of brain aging; provides update on its patent portfolio
Nov 20, 2019: DiamiR receives award from Alzheimer's Drug Discovery Foundation to accelerate development of microRNA biomarkers for Alzheimer's Disease
Sep 16, 2019: DiamiR announces additional $345,000 funding from the NIH for Development of CogniMIR
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: DiamiR LLC Pipeline Products and Ongoing Clinical Trials Overview
Table 2: DiamiR LLC Pipeline Products by Equipment Type
Table 3: DiamiR LLC Pipeline Products by Indication
Table 4: DiamiR LLC, Key Facts
Table 5: DiamiR LLC, Major Products and Services
Table 6: DiamiR LLC Number of Pipeline Products by Development Stage
Table 7: DiamiR LLC Pipeline Products Summary by Development Stage
Table 8: CogniMIR - Product Status
Table 9: CogniMIR - Product Description
Table 10: Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Status
Table 11: Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Description
Table 12: Diagnostic Assay - Frontotemporal Degeneration - Product Status
Table 13: Diagnostic Assay - Frontotemporal Degeneration - Product Description
Table 14: Diagnostic Assay - Parkinson's Disease - Product Status
Table 15: Diagnostic Assay - Parkinson's Disease - Product Description
Table 16: Diagnostic Assay - Rett Syndrome - Product Status
Table 17: Diagnostic Assay - Rett Syndrome - Product Description
Table 18: Mdx Test - Brain Aging - Product Status
Table 19: Mdx Test - Brain Aging - Product Description
Table 20: Mdx Test - MCI-AD Progression - Product Status
Table 21: Mdx Test - MCI-AD Progression - Product Description
Table 22: Mdx Test - Mild Cognitive Impairment - Product Status
Table 23: Mdx Test - Mild Cognitive Impairment - Product Description
Table 24: Universal Screening Test - Product Status
Table 25: Universal Screening Test - Product Description
Table 26: DiamiR LLC, Key Employees
Table 27: Glossary
List of Figures
Figure 1: DiamiR LLC Pipeline Products by Equipment Type
Figure 2: DiamiR LLC Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings